306 related articles for article (PubMed ID: 30178341)
21. Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide.
Graham C; Barsoum I; Kim J; Black M; Siemens RD
Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162279
[TBL] [Abstract][Full Text] [Related]
22. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
[TBL] [Abstract][Full Text] [Related]
23. TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia.
Kim KW; Lee SJ; Kim JC
Exp Eye Res; 2017 Nov; 164():74-81. PubMed ID: 28803935
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
[TBL] [Abstract][Full Text] [Related]
25. Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway.
Filippi I; Morena E; Aldinucci C; Carraro F; Sozzani S; Naldini A
J Cell Physiol; 2014 Dec; 229(12):2067-76. PubMed ID: 24818793
[TBL] [Abstract][Full Text] [Related]
26. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
27. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
28. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
29. Tumor Oxygenation Status: Facts and Fallacies.
Vaupel P; Mayer A
Adv Exp Med Biol; 2017; 977():91-99. PubMed ID: 28685432
[TBL] [Abstract][Full Text] [Related]
30. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
33. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response.
Noman MZ; Messai Y; Carré T; Akalay I; Méron M; Janji B; Hasmim M; Chouaib S
Crit Rev Immunol; 2011; 31(5):357-77. PubMed ID: 22142164
[TBL] [Abstract][Full Text] [Related]
34. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factors: a central link between inflammation and cancer.
Triner D; Shah YM
J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
[TBL] [Abstract][Full Text] [Related]
36. The role of hypoxia-inducible factor 1 in tumor immune evasion.
You L; Wu W; Wang X; Fang L; Adam V; Nepovimova E; Wu Q; Kuca K
Med Res Rev; 2021 May; 41(3):1622-1643. PubMed ID: 33305856
[TBL] [Abstract][Full Text] [Related]
37. The impact of hypoxia on immune state in cancer.
Mortezaee K; Majidpoor J
Life Sci; 2021 Dec; 286():120057. PubMed ID: 34662552
[TBL] [Abstract][Full Text] [Related]
38. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
40. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]